{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:51:40Z","timestamp":1791899500085,"version":"4.3.4"},"reference-count":78,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","license":[{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key Technology Research and Development Program of the 13th National 5-year Development Plan","award":["2016YFC1304103"],"award-info":[{"award-number":["2016YFC1304103"]}]},{"name":"Liaoning Province Revitalization Liaoning Talents Plan","award":["XLYC1805002"],"award-info":[{"award-number":["XLYC1805002"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>By evaluating S100 calcium binding protein A9 (S100A9) and Klebs von den Lungen-6 (KL-6) expression in patients with 4 common interstitial lung diseases (ILDs), we aimed to investigate whether S100A9 or KL-6 can be of any value in the differential diagnosis of these ILDs and simultaneously signal the disease progression.<\/jats:p>\n            <jats:p>We collected the data of patients diagnosed with the 4 ILDs and underwent fiber-optic bronchoscopy and BAL in the First Affiliated Hospital, China Medical University from January 2012 to December 2020. The data related to BGA, C-reactive protein, pulmonary function test, total number and fraction of cells, T lymphocyte subsets in bronchoalveolar lavage fluid (BALF), and the expression of S100A9 and KL-6 in BALF and serum were collected. We analyzed, whether S100A9 or KL-6 could serve as a biomarker for differential diagnosis between the 4 common ILDs; whether the levels of S100A9 and KL-6 correlated with each other; whether they were correlated with other clinical parameters and disease severity.<\/jats:p>\n            <jats:p>This study included 98 patients, 37 patients with idiopathic pulmonary fibrosis (IPF), 12 with hypersensitivity pneumonitis, 13 with connective tissue disease-associated ILD, and 36 with sarcoidosis (SAR): stage I (18), stage II (9), stage III (5), and stage IV (4). The expression of KL-6 in BALF was significantly higher in IPF patients than other 3 groups (all <jats:italic toggle=\"yes\">P<\/jats:italic>-value\u200a&lt;\u200a.05). However, there was no significant difference in the levels of S100A9 in BALF and serum between the 4 groups (<jats:italic toggle=\"yes\">P<\/jats:italic>-value\u200a&gt;\u200a.05). The levels of S100A9 in BALF of IPF patients was positively and significantly correlated with KL-6 expression and the percentage of neutrophils in BALF (<jats:italic toggle=\"yes\">P<\/jats:italic>-value\u200a&lt;\u200a.05). Along with the stage increase of SAR patients, the level of S100A9 in BALF gradually increased, which was negatively and significantly correlated with the forced vital capacity\/predicted, carbon monoxide diffusing capacity\/predicted%, and PaO<jats:sub>2<\/jats:sub> (all <jats:italic toggle=\"yes\">P<\/jats:italic>-value\u200a&lt;\u200a.05).<\/jats:p>\n            <jats:p>The expression of KL-6 in BALF can be used as a biomarker to differentiate IPF from the other 3 common ILDs. While, this was not the case with expression of S100A9 in BALF and serum. However, the expression S100A9 in BALF is useful to indicate the progression of SAR. Thus, simultaneous measurement of KL-6 and S100A9 levels in BALF makes more sense in differential diagnosing of the 4 common ILDS.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000029198","type":"journal-article","created":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T19:00:06Z","timestamp":1651777206000},"page":"e29198","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Expression of S100A9 and KL-6 in common interstitial lung diseases"],"prefix":"10.1097","volume":"101","author":[{"given":"Li","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Institute of Respiratory Disease, The First Hospital of China Medical University, Shenyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yabin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Institute of Respiratory Disease, The First Hospital of China Medical University, Shenyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Institute of Respiratory Disease, The First Hospital of China Medical University, Shenyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Institute of Respiratory Disease, The First Hospital of China Medical University, Shenyang, China"},{"name":"Department of Geriatric Respiratory, The First Hospital of Kunming Medical University, Kunming, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Institute of Respiratory Disease, The First Hospital of China Medical University, Shenyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Institute of Respiratory Disease, The First Hospital of China Medical University, Shenyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0097-509X","authenticated-orcid":false,"given":"Qiuyue","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Institute of Respiratory Disease, The First Hospital of China Medical University, Shenyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1183\/09059180.00009113","article-title":"Interstitial lung disease","volume":"23","author":"Antoniou","year":"2014","journal-title":"Eur Respir Rev"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3343\/alm.2019.39.3.245","article-title":"Analytical and clinical performance of the Nanopia Krebs von den Lungen 6 assay in Korean patients with interstitial lung diseases","volume":"39","author":"Cho","year":"2019","journal-title":"Ann Lab Med"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/ar3097","article-title":"Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management","volume":"12","author":"Castelino","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S2213-2600(16)30033-9","article-title":"Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study","volume":"4","author":"Walsh","year":"2016","journal-title":"Lancet Respir Med"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.semarthrit.2020.01.006","article-title":"Circulating lung biomarkers in idiopathic lung fibrosis and interstitial lung diseases associated with connective tissue diseases: where do we stand?","volume":"50","author":"Elhai","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1093\/rheumatology\/kez571","article-title":"Lung ultrasound B-lines and serum KL-6 correlate with the severity of idiopathic inflammatory myositis-associated interstitial lung disease","volume":"59","author":"Wang","year":"2020","journal-title":"Rheumatology (Oxford, England)"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10753-018-00955-2","article-title":"Calgranulin B and KL-6 in bronchoalveolar lavage of patients with IPF and NSIP","volume":"42","author":"Bennett","year":"2019","journal-title":"Inflammation"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10753-008-9085-z","article-title":"Calgranulin B (S100A9) levels in bronchoalveolar lavage fluid of patients with interstitial lung diseases","volume":"31","author":"Bargagli","year":"2008","journal-title":"Inflammation"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s40744-021-00288-x","article-title":"Serum KL-6, CA19-9, CA125 and CEA are diagnostic biomarkers for rheumatoid arthritis-associated interstitial lung disease in the Chinese population","volume":"8","author":"Zheng","year":"2021","journal-title":"Rheumatol Therapy"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13075-021-02586-9","article-title":"The role of lung ultrasound B-lines and serum KL-6 in the screening and follow-up of rheumatoid arthritis patients for an identification of interstitial lung disease: review of the literature, proposal for a preliminary algorithm, and clinical application to cases","volume":"23","author":"Wang","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1165\/rcmb.2018-0217OC","article-title":"The innate immune protein S100A9 protects from T-helper cell type 2-mediated allergic airway inflammation","volume":"61","author":"Palmer","year":"2019","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12890-020-01226-3","article-title":"Serum levels of interleukins and S100A8\/A9 correlate with clinical severity in patients with dermatomyositis-associated interstitial lung disease","volume":"20","author":"Lou","year":"2020","journal-title":"BMC Pulm Med"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.rmed.2011.12.010","article-title":"S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis","volume":"106","author":"Hara","year":"2012","journal-title":"Respir Med"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"e13543","DOI":"10.1111\/eci.13543","article-title":"Prognostic role of KL-6 in SSc-ILD patients with pleuroparenchymal fibroelastosis","volume":"51","author":"d\u2019Alessandro","year":"2021","journal-title":"Eur J Clin Investig"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10753-010-9210-7","article-title":"Calgranulin B (S100A9\/MRP14): a key molecule in idiopathic pulmonary fibrosis?","volume":"34","author":"Bargagli","year":"2011","journal-title":"Inflammation"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.3389\/fimmu.2019.02617","article-title":"Neutrophil extracellular traps induce tissue-invasive monocytes in granulomatosis with polyangiitis","volume":"10","author":"Akiyama","year":"2019","journal-title":"Front Immunol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2217\/bmm-2019-0545","article-title":"Krebs von den Lungen-6 as a biomarker for disease severity assessment in interstitial lung disease: a comprehensive review","volume":"14","author":"d\u2019Alessandro","year":"2020","journal-title":"Biomark Med"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1753466620963015","DOI":"10.1177\/1753466620963015","article-title":"Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients","volume":"14","author":"Feng","year":"2020","journal-title":"Therap Adv Respir Dis"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.21037\/jtd.2018.07.76","article-title":"Sequential changes of serum KL-6 predict the progression of interstitial lung disease","volume":"10","author":"Jiang","year":"2018","journal-title":"J Thorac Dis"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13075-019-1835-9","article-title":"Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease","volume":"21","author":"Lee","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/art.41020","article-title":"Pneumoproteins KL-6 and CCL-18 predict progression of interstitial lung disease in systemic sclerosis","volume":"71","author":"Volkmann","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R22-20250504","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00019-2016","article-title":"Importance of serial changes in biomarkers in idiopathic pulmonary fibrosis","volume":"3","author":"Sokai","year":"2017","journal-title":"ERJ Open Res"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1111\/crj.12946","article-title":"The serum KL-6 levels in untreated idiopathic pulmonary fibrosis can naturally decline in association with disease progression","volume":"12","author":"Ishii","year":"2018","journal-title":"Clin Respir J"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"262","DOI":"10.21037\/atm.2019.05.33","article-title":"A retrospective study of the tolerability of nintedanib for severe idiopathic pulmonary fibrosis in the real world","volume":"7","author":"Nakamura","year":"2019","journal-title":"Ann Transl Med"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00403-014-1453-y","article-title":"Clinicopathological roles of S100A8 and S100A9 in cutaneous squamous cell carcinoma in vivo and in vitro","volume":"306","author":"Choi","year":"2014","journal-title":"Arch Dermatol Res"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"e110421","DOI":"10.1371\/journal.pone.0110421","article-title":"The pro-apoptotic and pro-inflammatory effects of calprotectin on human periodontal ligament cells","volume":"9","author":"Zheng","year":"2014","journal-title":"PLoS One"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jdermsci.2016.04.006","article-title":"Paquinimod reduces skin fibrosis in tight skin 1 mice, an experimental model of systemic sclerosis","volume":"83","author":"Stenstrom","year":"2016","journal-title":"J Dermatol Sci"},{"key":"R28-20250504","first-page":"194","article-title":"S100A9 aggravates bleomycin-induced dermal fibrosis in mice via activation of ERK1\/2 MAPK and NF-kappaB pathways","volume":"21","author":"Xu","year":"2018","journal-title":"Iran J Basic Med Sci"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1182\/blood.V82.6.1875.1875","article-title":"MRP8 and MRP14, S-100-like proteins associated with myeloid differentiation, are translocated to plasma membrane and intermediate filaments in a calcium-dependent manner","volume":"82","author":"Roth","year":"1993","journal-title":"Blood"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00109-020-02001-x","article-title":"The heterodimer S100A8\/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis","volume":"99","author":"Araki","year":"2020","journal-title":"J Mol Med (Berl)"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2249.2010.04181.x","article-title":"MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases","volume":"161","author":"Korthagen","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.intimp.2012.08.008","article-title":"A novel tylophorine analog NK-007 ameliorates colitis through inhibition of innate immune response","volume":"14","author":"Wen","year":"2012","journal-title":"Int Immunopharmacol"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1034\/j.1399-3003.1999.14d02.x","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders","volume":"14","author":"Costabel","year":"1999","journal-title":"Eur Respir J"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"R36-20250504","first-page":"151","article-title":"Serum marker KL-6\/MUC1 for the diagnosis and management of interstitial pneumonitis","volume":"46","author":"Kohno","year":"1999","journal-title":"J Med Invest"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1034\/j.1399-3003.1999.14d02.x","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders","volume":"14","author":"Costabel","year":"1999","journal-title":"Eur Respir J"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0091-6749(99)70507-5","article-title":"Chronic hypersensitivity pneumonitis in Japan: a nationwide epidemiologic survey","volume":"103","author":"Yoshizawa","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1164\/rccm.202005-2032ST","article-title":"Diagnosis of hypersensitivity pneumonitis in adults. An official ATS\/JRS\/ALAT clinical practice guideline","volume":"202","author":"Raghu","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.chest.2017.07.008","article-title":"Predictors of mortality in pulmonary sarcoidosis","volume":"153","author":"Kirkil","year":"2018","journal-title":"Chest"},{"key":"R41-20250504","article-title":"Sample Size Tables for Clinical Studies","author":"Machin","year":"1997"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"180076","DOI":"10.1183\/16000617.0076-2018","article-title":"Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases","volume":"27","author":"Cottin","year":"2018","journal-title":"Eur Respir Rev"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"20181003","DOI":"10.1259\/bjr.20181003","article-title":"Idiopathic pulmonary fibrosis: the radiologist's role in making the diagnosis","volume":"92","author":"Mohning","year":"2019","journal-title":"Br J Radiol"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1513\/AnnalsATS.201408-350OC","article-title":"Validation of inhalation provocation test in chronic bird-related hypersensitivity pneumonitis and new prediction score","volume":"12","author":"Ishizuka","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1183\/09059180.00008613","article-title":"Neglected evidence in idiopathic pulmonary fibrosis and the importance of early diagnosis and treatment","volume":"23","author":"Cottin","year":"2014","journal-title":"Eur Respir Rev"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.resinv.2018.06.001","article-title":"Significance of molecular biomarkers in idiopathic pulmonary fibrosis: a mini review","volume":"56","author":"Chiba","year":"2018","journal-title":"Respir Investig"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00408-014-9647-9","article-title":"Evaluation of circulating YKL-40 levels in idiopathic interstitial pneumonias","volume":"192","author":"Korthagen","year":"2014","journal-title":"Lung"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.resinv.2019.02.003","article-title":"Evaluation and management of idiopathic pulmonary fibrosis","volume":"57","author":"Kishaba","year":"2019","journal-title":"Respir Investig"},{"key":"R50-20250504","first-page":"228","article-title":"Biomarkers to identify ILD and predict lung function decline in scleroderma lung disease or idiopathic pulmonary fibrosis","volume":"32","author":"Kennedy","year":"2015","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"e7083","DOI":"10.1097\/MD.0000000000007083","article-title":"Impact of serum SP-A and SP-D levels on comparison and prognosis of idiopathic pulmonary fibrosis: a systematic review and meta-analysis","volume":"96","author":"Wang","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"R52-20250504","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0165-2478(00)00164-4","article-title":"MRP8\/MRP14, CD11b and HLA-DR expression of alveolar macrophages in pneumonia","volume":"71","author":"Buhling","year":"2000","journal-title":"Immunol Lett"},{"key":"R53-20250504","doi-asserted-by":"crossref","first-page":"362","DOI":"10.21037\/jtd.2017.02.48","article-title":"Serum KL-6 and surfactant protein-D as monitoring and predictive markers of interstitial lung disease in patients with systemic sclerosis and mixed connective tissue disease","volume":"9","author":"Yamakawa","year":"2017","journal-title":"J Thorac Dis"},{"key":"R54-20250504","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1272\/jnms.81.364","article-title":"Serum KL-6 elevation and possible pulmonary involvement in patients with rheumatoid arthritis treated with biological agents","volume":"81","author":"Takahashi","year":"2014","journal-title":"J Nippon Med Sch"},{"key":"R55-20250504","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1007\/s10067-019-04501-9","article-title":"Serum KL-6 is associated with the severity of interstitial lung disease in Chinese patients with polymyositis and dermatomyositis","volume":"38","author":"Hu","year":"2019","journal-title":"Clin Rheumatol"},{"key":"R56-20250504","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2169\/internalmedicine.1890-18","article-title":"Remarkable improvement in a patient with idiopathic pulmonary fibrosis after treatment with nintedanib","volume":"58","author":"Nakano","year":"2019","journal-title":"Intern Med"},{"key":"R57-20250504","doi-asserted-by":"crossref","first-page":"e00215","DOI":"10.1002\/rcr2.215","article-title":"Treatment with nintedanib for acute exacerbation of idiopathic pulmonary fibrosis","volume":"5","author":"Tomioka","year":"2017","journal-title":"Respirol Case Rep"},{"key":"R58-20250504","article-title":"Pirfenidone improves familial idiopathic pulmonary fibrosis without affecting serum periostin levels","volume":"55","author":"Koga","year":"2019","journal-title":"Medicina (Kaunas, Lithuania)"},{"key":"R59-20250504","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/crj.12631","article-title":"Risk factors for acute exacerbation of idiopathic pulmonary fibrosis: a systematic review and meta-analysis","volume":"12","author":"Qiu","year":"2018","journal-title":"Clin Respir J"},{"key":"R60-20250504","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.resinv.2016.09.003","article-title":"Prognostic value of serial serum KL-6 measurements in patients with idiopathic pulmonary fibrosis","volume":"55","author":"Wakamatsu","year":"2017","journal-title":"Respir Investig"},{"key":"R61-20250504","first-page":"4759040","article-title":"Comparative study of circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as disease markers of idiopathic pulmonary fibrosis","volume":"2016","author":"Hamai","year":"2016","journal-title":"Dis Mark"},{"key":"R62-20250504","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.rmed.2014.04.009","article-title":"Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosis","volume":"108","author":"Ohshimo","year":"2014","journal-title":"Respir Med"},{"key":"R63-20250504","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.21037\/jtd.2018.07.76","article-title":"Sequential changes of serum KL-6 predict the progression of interstitial lung disease","volume":"10","author":"Jiang","year":"2018","journal-title":"Journal of thoracic disease"},{"key":"R64-20250504","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.rmed.2018.06.022","article-title":"Pleuroparenchymal fibroelastosis diagnosed by multidisciplinary discussions in Japan","volume":"141","author":"Ishii","year":"2018","journal-title":"Respir Med"},{"key":"R65-20250504","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13075-020-02190-3","article-title":"Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis","volume":"22","author":"Jarlborg","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"R66-20250504","doi-asserted-by":"crossref","first-page":"108375","DOI":"10.1016\/j.clim.2020.108375","article-title":"Differential analysis of serum and urine S100 proteins in juvenile-onset systemic lupus erythematosus (jSLE)","volume":"214","author":"Donohue","year":"2020","journal-title":"Clin Immunol (Orlando, Fla)"},{"key":"R67-20250504","first-page":"194","article-title":"S100A9 aggravates bleomycin-induced dermal fibrosis in mice via activation of ERK1\/2 MAPK and NF-\u03baB pathways","volume":"21","author":"Xu","year":"2018","journal-title":"Iran J Basic Med Sci"},{"key":"R68-20250504","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cca.2021.05.028","article-title":"The S100 protein family in lung cancer","volume":"520","author":"Wang","year":"2021","journal-title":"Clin Chim Acta"},{"key":"R69-20250504","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3904\/kjim.2014.29.1.12","article-title":"S100A8\/A9 as a biomarker for synovial inflammation and joint damage in patients with rheumatoid arthritis","volume":"29","author":"Kang","year":"2014","journal-title":"Korean J Intern Med"},{"key":"R70-20250504","first-page":"181","article-title":"Proteomic study of sera from patients with bladder cancer: usefulness of S100A8 and S100A9 proteins","volume":"7","author":"Minami","year":"2010","journal-title":"Cancer Genom Proteom"},{"key":"R71-20250504","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1189\/jlb.0603294","article-title":"Monosodium urate monohydrate crystals induce the release of the proinflammatory protein S100A8\/A9 from neutrophils","volume":"76","author":"Ryckman","year":"2004","journal-title":"J Leukoc Biol"},{"key":"R72-20250504","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1107\/S090744490100957X","article-title":"Expression, purification, crystallization and preliminary X-ray diffraction analysis of the human calcium-binding protein MRP14 (S100A9)","volume":"57","author":"Itou","year":"2001","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"R73-20250504","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2249.1990.tb05301.x","article-title":"Differential expression of the calcium-binding proteins MRP8 and MRP14 in granulomatous conditions: an immunohistochemical study","volume":"81","author":"Delabie","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"R74-20250504","doi-asserted-by":"crossref","first-page":"106534","DOI":"10.1016\/j.rmed.2021.106534","article-title":"Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease","volume":"186","author":"Kono","year":"2021","journal-title":"Respir Med"},{"key":"R75-20250504","doi-asserted-by":"crossref","first-page":"e13153","DOI":"10.1111\/eci.13153","article-title":"mRNA expression profile of bronchoalveolar lavage fluid cells from patients with idiopathic pulmonary fibrosis and sarcoidosis","volume":"49","author":"Papli\u0144ska-Goryca","year":"2019","journal-title":"Eur J Clin Investig"},{"key":"R76-20250504","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.yexcr.2005.10.013","article-title":"S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells","volume":"312","author":"Hermani","year":"2006","journal-title":"Exp Cell Res"},{"key":"R77-20250504","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/rheumatology\/kei244","article-title":"Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients","volume":"45","author":"Tan","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"R78-20250504","first-page":"2063","article-title":"Specific proteins identified in whole saliva from patients with diffuse systemic sclerosis","volume":"34","author":"Giusti","year":"2007","journal-title":"J Rheumatol"},{"key":"R79-20250504","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2213-2600(18)30064-X","article-title":"Pulmonary sarcoidosis","volume":"6","author":"Spagnolo","year":"2018","journal-title":"Lancet Respir Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029198","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T03:14:12Z","timestamp":1746328452000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":78,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029198","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,29]]},"assertion":[{"value":"2021-09-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}